MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Novocure Ltd

Gesloten

SectorGezondheidszorg

17.88 2.29

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.13

Max

17.92

Belangrijke statistieken

By Trading Economics

Inkomsten

-35M

-66M

Verkoop

6.2M

161M

EPS

-0.61

Winstmarge

-40.878

Werknemers

1,488

EBITDA

19M

-11M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+118.04% upside

Dividenden

By Dow Jones

Volgende Winsten

24 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-226M

2.1B

Vorige openingsprijs

15.59

Vorige sluitingsprijs

17.88

Nieuwssentiment

By Acuity

50%

50%

180 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Novocure Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 okt 2024, 21:35 UTC

Belangrijke Marktbewegers

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

16 okt 2024, 11:43 UTC

Winsten

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, J.B. Hunt, DJT, Novocure, and More -- Barrons.com

16 okt 2024, 10:40 UTC

Winsten

These Stocks Are Moving the Most Today: ASML, Nvidia, United Airlines, J.B. Hunt, DJT, Novocure, Morgan Stanley, and More -- Barrons.com

16 okt 2024, 09:27 UTC

Populaire aandelen

Stocks to Watch Wednesday: ASML, Morgan Stanley, Novocure, TSM -- WSJ

Peer Vergelijking

Prijswijziging

Novocure Ltd Prognose

Koersdoel

By TipRanks

118.04% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 38.2 USD  118.04%

Hoogste 42 USD

Laagste 33 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novocure Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technische score

By Trading Central

N/A / 18.84Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

180 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.